Executive Summary
This overnight filing cycle reveals a market bifurcated between aggressive capital deployment and strategic retrenchment. A dominant theme is the surge in M&A and capital allocation, with CareTrust REIT executing a landmark £1.1B UK care home acquisition and Flowco Holdings closing a $113M energy services deal, both raising full-year guidance.
Conversely, a wave of insider selling—including a $2.95M disposal by Alto Neuroscience's CFO and a $2.62M sale by Marvell Technology's President—signals potential conviction gaps at the executive level. Period-over-period data highlights acute distress in the pet sector, with Dogness International reporting a net loss of $27.6M, widening from a $5.1M loss, while NIO's vehicle deliveries declined 3.7% YoY despite a QoQ improvement. The most critical development is the proposed going-private of Utz Brands at a 91% premium, offering a clear arbitrage opportunity, while the complete exit of GIC from Claritev Corp and a forced EGM at Scully Royalty point to underlying governance and strategic shifts. The overall picture is one of high-velocity capital rotation, where acquirers are rewarded and laggards face intensified insider skepticism.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4 · Schedule 13D · Schedule 13G · 20-F · DEF 14A · DEFA14A · 8-K · DEFM14A · S-3
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from September 25, 2026.
Investment Signals (10)
- CareTrust REIT ↓ (BULLISH)▲
Acquired 45 UK care homes for ~£1.1B, closed first 24 for $764M, raised full-year 2026 guidance, and expects mid-to-high 7% yields. CEO/insider buying expected to follow this accretive deployment.
- Flowco Holdings ↓ (BULLISH)▲
Closed $113M acquisition of Lifting Solutions, funded via ABL facility, expected to be accretive to earnings and free cash flow per share. Raises guidance, expanding into Canada and international markets.
- Utz Brands ↓ (BULLISH)▲
Going-private merger at $14.25/share represents a 91% premium over the July 20, 2026 closing price. A clear arbitrage opportunity for current holders ahead of the November 13 vote.
- GameStop ↓ (BULLISH)▲
Director Turner Nat bought $255K in stock at $24.33, a direct insider vote of confidence in the company's turnaround strategy amid a volatile retail environment.
- BBVA (BULLISH)▲
Executed first tranche of a €1B share buyback (0.73% of capital), with shares to be retired. Signals strong capital return policy and confidence in balance sheet strength.
- Alto Neuroscience ↓ (BEARISH)▲
CFO Smith Nicholas Conrad sold 110,830 shares for $2.95M, reducing his holdings by ~82%. This massive liquidation by the top financial officer is a severe bearish signal on near-term valuation.
- Marvell Technology ↓ (BEARISH)▲
President & COO Koopmans Chris sold $2.62M in stock at $262.05 under a 10b5-1 plan. While pre-planned, the magnitude ($2.62M) is a significant supply overhang and signals potential insider concern.
- Autohome Inc. ↓ (BEARISH)▲
Three insiders (CFO, CTO, Director) sold a combined ~$261K in stock at $5.29 on the same day, indicating coordinated insider pessimism or a liquidity event.
- Dogness International ↓ (BEARISH)▲
Revenue declined 23.3% YoY to $15.9M, while operating expenses surged 165%, resulting in a net loss of $27.6M (vs $5.1M loss last year). The business model is deteriorating rapidly.
- Claritev Corp ↓ (BEARISH)▲
GIC Private Ltd filed a complete exit, reporting 0% beneficial ownership. A sophisticated institutional investor fully liquidating a position is a strong negative signal on the company's prospects.
Risk Flags (9)
- Dogness International / Financial Distress↓ [HIGH RISK]▼
Net loss widened 441% YoY to $27.6M from $5.1M. Revenue collapsed 23.3% YoY while OpEx surged 165%. The company also flagged risks around PRC legal enforcement and dividend payment limitations.
- Alto Neuroscience / Insider Liquidation↓ [HIGH RISK]▼
CFO sold 82% of his holdings ($2.95M) immediately after exercising options. This pattern of 'exercise-and-sell' suggests zero conviction in holding the stock, a major red flag for a pre-revenue biotech.
- Autohome Inc. / Coordinated Insider Selling↓ [HIGH RISK]▼
Three top executives (CFO, CTO, Director) sold shares simultaneously at $5.29. This coordinated insider selling is a classic warning sign of deteriorating fundamentals or an upcoming negative catalyst.
- Marvell Technology / Large Insider Sale↓ [MEDIUM RISK]▼
President & COO sold $2.62M in stock. Even under a 10b5-1 plan, the sheer size of the sale creates a negative sentiment overhang and raises questions about management's long-term outlook.
- PHOTRONICS INC / Director Selling↓ [MEDIUM RISK]▼
Director Lee Kang Jyh sold $308K in stock. While not a massive percentage of holdings, a director sale at this level signals a lack of confidence at the board level.
- Scully Royalty Ltd. / Shareholder Activism↓ [HIGH RISK]▼
Shareholders holding 20% of voting rights forced an EGM for January 12, 2027. The nature of the resolutions is undisclosed, but this level of shareholder requisition implies significant governance or strategic conflict.
- KEPCO / Government Intervention Risk [MEDIUM RISK]▼
A government proposal to merge five of its power generation subsidiaries is pending. While details are unconfirmed, forced restructuring creates operational uncertainty and potential value destruction for minority shareholders.
- NIO Inc. / Stalling Growth↓ [MEDIUM RISK]▼
Q3 2026 deliveries declined 3.7% YoY to 61,855. While up 10.2% QoQ, the YoY decline in a growing EV market signals market share loss or demand saturation.
- Gulf Resources / Dilution Risk↓ [MEDIUM RISK]▼
Seeking to increase authorized shares under its incentive plan by 2,043% (from 14,000 to 300,000). Massive potential dilution for existing shareholders, even if intended for talent retention.
Opportunities (9)
- Utz Brands / Merger Arbitrage↓ (OPPORTUNITY)◆
Trading at $14.25/share in a going-private deal with a 91% premium. With the special meeting on Nov 13, 2026, there is a clear, time-bound arbitrage for current holders to capture the premium.
- CareTrust REIT / UK Care Home Expansion↓ (OPPORTUNITY)◆
Acquiring 45 UK homes for £1.1B with mid-to-high 7% yields. The remaining 21 homes closing through 2027 provide a multi-year catalyst for earnings growth.
- Flowco Holdings / Energy Services Roll-up↓ (OPPORTUNITY)◆
The $113M acquisition of Lifting Solutions adds continuous rod and PCP technologies. The contingent consideration (up to C$10M) aligns seller incentives with 2027 performance, creating a potential beat-and-raise scenario.
- BBVA / Capital Return via Buyback (OPPORTUNITY)◆
Executing a €1B buyback (0.73% of capital) for share retirement. This is a direct, tax-efficient return of capital to shareholders and signals strong capital discipline.
- GameStop / Insider Conviction↓ (OPPORTUNITY)◆
Director Nat Turner's $255K open-market purchase at $24.33 is a strong vote of confidence. If the turnaround thesis is correct, this is a leading indicator of value creation.
- Lexaria Bioscience / DehydraTECH Data↓ (OPPORTUNITY)◆
GLP-1 study showed a 54.9% reduction in GI adverse events for semaglutide and 60.6% for tirzepatide. While weight loss was not superior, the safety profile is a differentiated asset for a partnership or licensing deal.
- Angel Studios / Toothy Cow Merger↓ (OPPORTUNITY)◆
Acquiring Toothy Cow Productions in a tax-free reorganization. If the content pipeline is strong, this could unlock value for a studio trading at a discount to peers.
- Synaptics / Pending Transaction↓ (OPPORTUNITY)◆
Filed DEFA14A for a stockholder vote on a transaction with onsemi. The definitive proxy is filed; the outcome could unlock significant value if the deal closes at a premium.
- CLEANSPARK / Insider Exercise Pattern↓ (OPPORTUNITY)◆
Four directors exercised options at a low strike price, converting RSUs to common stock. While some shares were sold for taxes, the exercise itself signals a belief that the current price ($12.33) is below intrinsic value.
Sector Themes (6)
- Aggressive M&A and Capital Deployment (THEME)◆
Three major transactions closed in this cycle (CareTrust REIT £1.1B, Flowco $113M, Angel Studios/Toothy Cow). All acquirers raised guidance or signaled accretion, indicating a 'growth through acquisition' theme is being rewarded by markets.
- Insider Selling Wave in Tech and Biotech (THEME)◆
A cluster of high-value insider sales (Alto Neuroscience $2.95M, Marvell $2.62M, Autohome $261K) suggests a loss of conviction at the executive level in high-growth/high-risk sectors. This contrasts with the bullish M&A activity.
- Pet Sector Distress (THEME)◆
Dogness International reported a catastrophic 441% widening of net losses, while Autohome insiders sold stock. The pet sector, once a pandemic darling, is showing signs of severe demand normalization and cost inflation.
- Going-Private and De-SPAC Activity (THEME)◆
Utz Brands (91% premium) and Southport Acquisition Corp. II ($200M IPO) represent opposite ends of the SPAC/M&A lifecycle. The Utz deal offers a premium exit, while Southport's blank-check structure carries inherent dilution risks for new investors.
- Foreign Issuer Governance and Regulatory Risk (THEME)◆
Multiple foreign issuers (KEPCO, Dogness, Scully Royalty) face government intervention, shareholder activism, or regulatory hurdles. This creates a risk premium for investors in these names that must be actively managed.
- Capital Return vs. Capital Raising (THEME)◆
BBVA is returning €1B via buybacks, while Gulf Resources is seeking a 2,043% increase in authorized shares. This bifurcation highlights the divergence between cash-rich, mature companies and cash-burning growth companies.
Watch List (8)
- Utz Brands / Special Meeting↓ (WATCH)👁
Stockholder vote on $14.25/share going-private merger on November 13, 2026. Watch for institutional shareholder voting patterns and potential last-minute bids.
- 👁
21 homes under development with closings expected on a rolling basis throughout 2027. Monitor for execution risk and regulatory approvals in the UK.
- Scully Royalty Ltd. / EGM↓ (WATCH)👁
Forced EGM on January 12, 2027, in Hong Kong. The nature of the resolutions is unknown but the 20% requisition threshold implies significant discontent.
- KEPCO / Government Restructuring (WATCH)👁
Three-month deadline for details on the proposed merger of five power subsidiaries (by January 2, 2027). Watch for value destruction or unlocking depending on the final plan.
-
After the CFO's massive $2.95M sale, watch for any clinical trial updates or partnership announcements that could justify or condemn the insider's exit.
- NIO Inc. / Q4 2026 Deliveries↓ (WATCH)👁
After a 3.7% YoY decline in Q3, watch for the Q4 delivery report to see if the trend reverses or accelerates.
- Synaptics / onsemi Deal Vote↓ (WATCH)👁
The proposed transaction is pending stockholder approval. Watch for the special meeting date and any dissenting shareholder activity.
-
The $200M SPAC IPO at $10.00/unit will be a test of market appetite for blank-check vehicles. Watch for oversubscription and the 45-day over-allotment option.
Filing Analyses
(50)
01-10-2026
Director Bode John B was awarded 110,000 Common Stock. Bode John B holds 110,000 shares after the transaction.
- · Director Bode John B was awarded 110,000 Common Stock
01-10-2026
Director Cook Timothy Patrick was awarded 110,000 Common Stock. Cook Timothy Patrick holds 110,000 shares after the transaction.
- · Director Cook Timothy Patrick was awarded 110,000 Common Stock
01-10-2026
Director HOUSTON LINDA M was awarded 110,000 Common Stock. HOUSTON LINDA M holds 110,000 shares after the transaction.
- · Director HOUSTON LINDA M was awarded 110,000 Common Stock
01-10-2026
Director Cornelli Francesca was awarded 5,722 Class A Common Stock at $12.89 (~$73.8K). Cornelli Francesca holds 57,953 shares after the transaction.
- · Director Cornelli Francesca was awarded 5,722 Class A Common Stock at $12.89 (~$73.8K)
01-10-2026
Director HELFAND DAVID was awarded 6,886 Restricted Stock Units at $12.89 (~$88.8K).
- · Director HELFAND DAVID was awarded 6,886 Restricted Stock Units at $12.89 (~$88.8K)
01-10-2026
Director Turner Nat bought 10,462 Class A Common Stock at $24.33 (~$255K). Turner Nat holds 10,462 shares after the transaction.
- · Director Turner Nat bought 10,462 Class A Common Stock at $24.33 (~$255K)
01-10-2026
Director Malkin Stephen was awarded 4,849 Restricted Stock Units at $12.89 (~$62.5K).
- · Director Malkin Stephen was awarded 4,849 Restricted Stock Units at $12.89 (~$62.5K)
01-10-2026
Director SCOTT SAMUEL C III was awarded 5,722 Restricted Stock Units at $12.89 (~$73.8K).
- · Director SCOTT SAMUEL C III was awarded 5,722 Restricted Stock Units at $12.89 (~$73.8K)
01-10-2026
Director Lee Kang Jyh sold 10,000 COMMON STOCK at $30.75 (~$308K). Lee Kang Jyh holds 337,350 shares after the transaction.
- · Director Lee Kang Jyh sold 10,000 COMMON STOCK at $30.75 (~$308K)
01-10-2026
Gerald J. Ford and related entities filed Amendment No. 22 to Schedule 13D, disclosing beneficial ownership of 15,651,330 shares (27.3%) of Hilltop Holdings Inc. as of August 25, 2026. The filing reports that an $80 million loan previously secured by Mr. Ford's partnership interests in Diamond A Financial, L.P. has been fully repaid as of September 29, 2026, and the associated security interests have been terminated. No transactions in Hilltop securities were reported in the past sixty days.
- · The filing is Amendment No. 22 to Schedule 13D, filed on October 1, 2026.
- · Gerald J. Ford's beneficial ownership includes 15,544,674 shares via Financial LP and 98,789 shares via Turtle Creek Revocable Trust.
- · The $80 million loan was made by an affiliate of Mr. Ford and was repaid as of September 29, 2026.
- · No transactions in Hilltop securities were reported by the Reporting Persons during the past sixty days.
01-10-2026
Director Cavaleri Amanda exercised/converted 7,805 Common Stock. Cavaleri Amanda holds 137,605 shares after the transaction.
- · Director Cavaleri Amanda exercised/converted 7,805 Common Stock
- · Director Cavaleri Amanda exercised/converted 7,805 Restricted Stock Units
01-10-2026
Director Beynon Roger Paul exercised/converted 7,805 Common Stock. Beynon Roger Paul holds 155,827 shares after the transaction.
- · Director Beynon Roger Paul exercised/converted 7,805 Common Stock
- · Director Beynon Roger Paul exercised/converted 7,805 Restricted Stock Units
01-10-2026
Director McNeill Larry exercised/converted 7,805 Common Stock. McNeill Larry holds 319,083 shares after the transaction.
- · Director McNeill Larry exercised/converted 7,805 Common Stock
- · Director McNeill Larry exercised/converted 7,805 Restricted Stock Units
01-10-2026
Director Wood Thomas Leigh exercised/converted 7,805 Common Stock. Wood Thomas Leigh holds 71,737 shares after the transaction.
- · Director Wood Thomas Leigh exercised/converted 7,805 Common Stock
- · Director Wood Thomas Leigh exercised/converted 7,805 Restricted Stock Units
01-10-2026
Director Ortiz Christine was awarded 958 Common stock, par value $0.001. Ortiz Christine holds 26,815 shares after the transaction.
- · Director Ortiz Christine was awarded 958 Common stock, par value $0.001
01-10-2026
GIC Private Ltd and its affiliates (GIC Special Investments Private Limited and Viggo Investment Pte. Ltd.) filed a Schedule 13G/A with the SEC on October 1, 2026, disclosing that they have ceased to be beneficial owners of any shares of Claritev Corp (CTEV) Class A Common Stock. The filing reports 0 shares beneficially owned, representing 0% of the class, indicating a complete exit from their position as of September 22, 2026.
- · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(c).
- · The reporting persons disclaim membership in a group.
- · The filing certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.
01-10-2026
President and COO Koopmans Chris sold 10,000 Common Stock at $262.05 (~$2.62M). Koopmans Chris holds 207,941 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · President and COO Koopmans Chris sold 10,000 Common Stock at $262.05 (~$2.62M)
01-10-2026
Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.
01-10-2026
CTO, COO Monnig Taylor had withheld for taxes 13,123 Common Stock at $12.33 (~$162K). 4 transactions reported in total. Monnig Taylor holds 336,810 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CTO, COO Monnig Taylor exercised/converted 33,350 Common Stock
- · CTO, COO Monnig Taylor had withheld for taxes 13,123 Common Stock at $12.33 (~$162K)
- · CTO, COO Monnig Taylor sold 3,335 Common Stock at $12.33 (~$41.1K)
- · CTO, COO Monnig Taylor exercised/converted 33,350 Restricted Stock Units
01-10-2026
EVP, Chief Development Officer Garrison Scott Eugene had withheld for taxes 14,854 Common Stock at $12.33 (~$183K). Garrison Scott Eugene holds 385,946 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · EVP, Chief Development Officer Garrison Scott Eugene exercised/converted 33,350 Common Stock
- · EVP, Chief Development Officer Garrison Scott Eugene had withheld for taxes 14,854 Common Stock at $12.33 (~$183K)
- · EVP, Chief Development Officer Garrison Scott Eugene exercised/converted 33,500 Restricted Stock Units
01-10-2026
Chief Financial Officer Zeng Yan sold 9,316 Ordinary Shares at $5.29 (~$49.3K). Zeng Yan holds 160,624 shares after the transaction.
- · Chief Financial Officer Zeng Yan sold 9,316 Ordinary Shares at $5.29 (~$49.3K)
01-10-2026
Chief Technology Officer Xiang Bibo sold 5,588 Ordinary Shares at $5.29 (~$29.5K). Xiang Bibo holds 56,780 shares after the transaction.
- · Chief Technology Officer Xiang Bibo sold 5,588 Ordinary Shares at $5.29 (~$29.5K)
01-10-2026
Director Long Quan sold 34,400 Ordinary Shares at $5.29 (~$182K). Long Quan holds 175,984 shares after the transaction.
- · Director Long Quan sold 34,400 Ordinary Shares at $5.29 (~$182K)
01-10-2026
PRESIDENT AND CFO Smith Nicholas Conrad sold 110,830 Common Stock at $26.58 (~$2.95M). 9 transactions reported in total. Smith Nicholas Conrad holds 24,060 shares after the transaction.
- · PRESIDENT AND CFO Smith Nicholas Conrad exercised/converted 56,455 Common Stock at $2.35 (~$133K)
- · PRESIDENT AND CFO Smith Nicholas Conrad exercised/converted 54,375 Common Stock at $2.35 (~$128K)
- · PRESIDENT AND CFO Smith Nicholas Conrad sold 110,830 Common Stock at $26.58 (~$2.95M)
- · PRESIDENT AND CFO Smith Nicholas Conrad exercised/converted 24,056 Common Stock at $2.35 (~$56.5K)
- · PRESIDENT AND CFO Smith Nicholas Conrad sold 23,170 Common Stock at $25.78 (~$597K)
- · PRESIDENT AND CFO Smith Nicholas Conrad sold 886 Common Stock at $26.87 (~$23.8K)
- · PRESIDENT AND CFO Smith Nicholas Conrad exercised/converted 56,455 Employee Stock Option (Right to Buy)
- · PRESIDENT AND CFO Smith Nicholas Conrad exercised/converted 54,375 Employee Stock Option (Right to Buy)
01-10-2026
Chief Financial Officer Stewart Christopher P. had withheld for taxes 5,697 Common Stock at $12.36 (~$70.4K). Stewart Christopher P. holds 67,781 shares after the transaction.
- · Chief Financial Officer Stewart Christopher P. had withheld for taxes 5,697 Common Stock at $12.36 (~$70.4K)
01-10-2026
CEO and Chairman of the BOD Huang Victor gifted 200,000 Common Stock. This amends a previously filed Form 4. Huang Victor holds 3,832,207 shares after the transaction.
- · CEO and Chairman of the BOD Huang Victor gifted 200,000 Common Stock
01-10-2026
Dogness (International) Corp filed its annual 20-F for the fiscal year ended June 30, 2026, reporting a net loss of $27.6M, a significant widening from the $5.1M loss in fiscal 2025. Revenue declined 23.3% YoY to $15.9M, driven by drops in intelligent pet products and climbing hooks segments, while traditional pet products grew 11.6%. Operating expenses surged 165% to $31.4M, primarily due to increased R&D and marketing costs, leading to a much larger operating loss of $28.8M. The company also highlighted ongoing risks related to PRC legal enforcement, currency conversion restrictions, and dividend payment limitations.
- · Loss per share widened to $1.55 in fiscal 2026 from $0.38 in fiscal 2025.
- · International sales declined 20.2% YoY to $10.9M, while China domestic sales fell 29.3% to $5.0M.
- · Total liabilities remained nearly flat at $19.1M as of June 30, 2026, compared to $19.1M a year earlier.
- · The company transferred $6.0M to HK Dogness for working capital in fiscal 2025, up from $5.3M in fiscal 2024.
- · Operating loss surged to $28.8M in fiscal 2026 from $6.8M in fiscal 2025, driven by a 165% increase in operating expenses.
- · Gross margin declined to 16.0% in fiscal 2026 from 24.3% in fiscal 2025.
- · Current liabilities increased 24.5% to $7.6M as of June 30, 2026 from $6.1M a year earlier.
02-10-2026
Korea Electric Power Corporation (KEPCO) issued a clarification disclosure on October 2, 2026, regarding media reports from September 3, 2026, about a proposed government plan to merge five of its power generation subsidiaries into a single entity. The company states that the plan is a government proposal under the 'Plan for Functional Reform of Public Institutions' and that specific details have not yet been finalized. KEPCO will provide further updates when details are determined or within three months.
- · The clarification was issued in response to a report titled 'South Korea to merge five power generators, combine oil and gas firms in sweeping energy overhaul'.
- · The proposal involves merging five power generation subsidiaries of KEPCO into a single entity.
- · The company will re-disclose specific details within three months from October 2, 2026, if not determined earlier.
02-10-2026
Addex Therapeutics Ltd filed a Form 6-K with the SEC on October 2, 2026, to incorporate a press release by reference into its registration statements. The filing includes standard risk factor disclosures and forward-looking statement cautions, but contains no specific financial data, operational updates, or material business developments.
- · Filing incorporates press release into registration statements on Form F-3 (No. 333-291644) and Form S-8 (Nos. 333-255124 and 333-272515)
- · Company's Annual Report on Form 20-F for FY2025 was filed on May 15, 2026
- · No financial figures, operational metrics, or business developments were disclosed in this filing
02-10-2026
KE Holdings Inc. (BEKE) filed a Form 6-K with the SEC on October 2, 2026, reporting the grant of restricted share units (RSUs) under its equity incentive plan. The filing, signed by CFO Xu Tao, discloses the RSU grant as a routine corporate governance matter. No financial figures or performance metrics were provided in this filing.
- · Filing is a Form 6-K under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934
- · Commission File Number: 001-39436
- · Registrant address: Oriental Electronic Technology Building, No. 2 Chuangye Road, Haidian District, Beijing 100086, People's Republic of China
- · Exhibit 99.1 contains the announcement of the RSU grant
- · The company files annual reports under Form 20-F
02-10-2026
Gulf Resources, Inc. is seeking stockholder approval at its Annual Meeting to amend its 2025 Stock Incentive Plan, increasing authorized shares from 14,000 to 300,000 (an increase of 286,000 shares) to attract and retain talent. The filing also includes a proposal to ratify the appointment of independent accountants. The 2019 Plan will remain frozen with no new grants, and outstanding awards under both plans will continue under their respective terms.
- · The 2019 Plan will remain frozen upon adoption of the Amended 2025 Plan; no new awards will be granted under the 2019 Plan.
- · Outstanding awards under the 2019 Plan will continue to be governed by the 2019 Plan and applicable award agreements.
- · The Amended 2025 Plan will continue in effect until the 10th anniversary of the Effective Date, unless terminated sooner.
- · The Audit Committee recommends a vote 'FOR' ratification of the appointment of independent accountants.
- · The Board of Directors recommends a vote 'FOR' approval of the amendment to the 2025 Stock Incentive Plan.
02-10-2026
NIO Inc. reported September and third quarter 2026 delivery numbers. The company delivered 21,322 vehicles in September 2026, bringing Q3 2026 total deliveries to 61,855. While this represents a 10.2% increase from Q2 2026 deliveries of 56,128, it marks a 3.7% decline compared to Q3 2025 deliveries of 64,215, indicating mixed year-over-year performance.
- · September 2026 deliveries were 21,322 vehicles.
- · Q3 2026 total deliveries were 61,855 vehicles.
- · Q3 2026 deliveries declined 3.7% year-over-year compared to Q3 2025 deliveries of 64,215.
- · Sequentially, Q3 2026 deliveries grew 10.2% from Q2 2026 deliveries of 56,128.
02-10-2026
KB Financial Group Inc. has filed a Form 6-K with the SEC to disclose the nomination of Jae Keun Lee as an Executive Director for a three-year term. Mr. Lee currently serves as Chief Business Officer of Global, WM and SME at KB Financial Group and previously served as President and CEO of Kookmin Bank from 2022 to 2024. The nomination is subject to shareholder approval at the upcoming Annual General Meeting.
- · Jae Keun Lee was born in May 1966.
- · His term of office is 3 years.
- · This is a new appointment (not a re-appointment).
- · He has been Chief Business Officer of Global, WM and SME since January 2026.
- · He served as President and CEO of Kookmin Bank from January 2022 to December 2024.
- · His career includes roles in sales planning and as CFO of KB Financial Group in 2017.
02-10-2026
BBVA completed the execution of the First Tranche of its New Program Scheme share buyback, acquiring 40,204,840 own shares (approx. 0.73% of share capital) for a maximum amount of €1,000 million. The purchased shares will be used to reduce BBVA's share capital through redemption. The buyback was managed by HSBC Continental Europe, with final transactions on October 1, 2026.
- · The buyback execution is in accordance with EU Regulation No 596/2014.
- · The redemption of all acquired shares is expected to follow the First Tranche.
02-10-2026
Synaptics Inc. filed a DEFA14A proxy statement in connection with a proposed transaction that will be submitted to stockholders for approval. The filing provides forward-looking statements and directs investors to the forthcoming definitive proxy statement for details on the transaction and participant interests. No financial results or operational metrics were disclosed in this filing.
- · Synaptics' definitive proxy statement was filed with the SEC on September 15, 2026.
- · onsemi's definitive proxy statement was filed with the SEC on April 2, 2026.
- · The proposed transaction will be submitted to Synaptics stockholders at a special meeting.
- · Synaptics' CIK is 817720 for ownership disclosure filings.
02-10-2026
HDFC Bank Ltd announced the appointment of Mr. Anup Bagchi as an Additional Director and as the Managing Director & Chief Executive Officer, replacing Mr. Sashidhar Jagdishan. This is a key leadership change at the top of India's largest private sector bank. No financial figures or performance metrics were disclosed in this filing.
- · The appointment is effective from October 1, 2026.
- · Mr. Anup Bagchi was appointed as an Additional Director and Managing Director & CEO.
- · Mr. Sashidhar Jagdishan was replaced in the role.
02-10-2026
ASP Isotopes Inc. (ASPI) disclosed that ENDRA Life Sciences Inc. filed a Form S-4 Registration Statement with the SEC on October 2, 2026, in connection with the proposed merger of ASPI's subsidiary Noble Africa LLC into ENDRA. The merger, announced on June 25, 2026, involves the transfer of Noble Africa and its subsidiary Renergen Limited to ENDRA, with the combined company expected to list on Nasdaq. The filing is a procedural step in the merger process, and the transaction remains subject to stockholder approval and other conditions.
- · Merger Agreement signed on June 25, 2026
- · Merger Sub will merge with and into Noble Africa, with Noble Africa surviving as a wholly-owned subsidiary of ENDRA
- · Registration Statement on Form S-4 filed by ENDRA on October 2, 2026
- · Combined company expected to list on Nasdaq after closing
- · Potential debt funding from U.S. DFC or Standard Bank SA is anticipated
- · Renergen's Virginia Gas Project continuation and funding timeline are mentioned
02-10-2026
CareTrust REIT announced a definitive agreement to acquire 45 new UK care homes from LNT Care Developments for approximately £1.1 billion, with the first closing of 24 homes for £576 million (~$764 million) completed on October 1, 2026. The transaction is structured with a lease-up phase followed by a transition to a RIDEA/SHOP structure, expected to be accretive and generate mid-to-high 7% yields. The company also closed ~$488 million of other investments and raised its full-year 2026 guidance, reflecting strong investment activity, though the remaining 21 homes are subject to development and regulatory approvals.
- · First closing of 24 homes occurred on October 1, 2026; one additional home is completed and operating but closing subject to regulatory approval expected in October 2026.
- · Remaining 21 homes are under development, with closings expected on a rolling basis throughout 2027.
- · All homes will be leased to Crystal Care under triple-net leases with fixed annual escalators and renewal options during the Lease-up Phase.
- · SHOP Phase expected to begin between years two and four after each home's completion, with first transition anticipated by Q4 2027.
- · LNT has granted CareTrust an option to acquire the LNT platform in its entirety in the future.
- · Revised FY2026 guidance: net income $1.54-$1.57 per share, Normalized FFO $2.06-$2.09 per share, Normalized FAD $2.02-$2.05 per share.
- · Company has deliberately run below target leverage to maintain capacity for strategic opportunities.
- · LNT founder Lawrence Tomlinson has built more than 250 care homes; LNT delivers at a pace approaching 30 homes per year.
02-10-2026
Flowco Holdings Inc. (FLOC) closed its acquisition of Lifting Solutions Energy Services Inc. for approximately US$113 million in cash, funded under its ABL facility. The deal adds continuous rod and PCP technologies, expands Flowco's artificial lift portfolio, and provides a platform in Canada and international markets. The transaction is expected to be accretive to earnings and free cash flow per share, with sellers eligible for up to C$10 million in contingent consideration based on 2027 performance.
- · The acquisition was structured on a cash-free, debt-free basis.
- · Flowco funded the cash consideration with borrowings under its ABL facility.
- · The exchange rate used was 0.71 CAD/USD.
- · A conference call and webcast will be held on October 2, 2026 at 7:30 a.m. ET.
02-10-2026
Scully Royalty Ltd. has convened an Extraordinary General Meeting (EGM) for January 12, 2027, following a requisition from shareholders holding 20% of voting rights. The meeting will be held in Hong Kong to vote on resolutions specified in the requisition, the full text of which will be provided in the formal notice. The filing does not disclose the nature of the resolutions or any financial impact.
- · EGM date: January 12, 2027 at 10:00 a.m. Hong Kong time
- · Location: Unit 803, Dina House, Ruttonjee Centre, 11 Duddell Street, Hong Kong, SAR China
- · Requisition threshold: shareholders entitled to exercise 20% of voting rights
- · Resolutions will be set out in the formal notice per Article 16.5 of the company's amended and restated memorandum and articles of association
02-10-2026
Utz Brands, Inc. will hold a Special Meeting on November 13, 2026, for stockholders to vote on a proposed merger with an affiliate of Intersnack Group GmbH & Co. KG. Under the Merger Agreement, each share of Class A Common Stock will be converted into the right to receive $14.25 per share in cash, representing a 91% premium over the closing price on July 20, 2026. The transaction is a going-private deal that has been unanimously recommended by both a Special Committee and the Board (with two directors abstaining), but requires approval from a majority of outstanding shares and a majority of disinterested stockholders.
- · The Special Meeting will be held virtually at www.virtualshareholdermeeting.com/UTZ2026SM.
- · Record date for voting is September 28, 2026.
- · Shares of Class V Common Stock will be canceled for no consideration.
- · The Voting Agreement commits Dylan Lissette, Timothy Brown, and the Rice Family Foundation to vote in favor of the Transaction Proposal.
- · Approval requires both a majority of outstanding shares (Majority Approval) and a majority of disinterested stockholders (Unaffiliated Stockholder Approval).
- · Failure to vote counts as a vote AGAINST the Transaction Proposal for the Majority Approval requirement but has no effect on the Unaffiliated Stockholder Approval requirement.
- · The Board recommendation had two abstentions (Lissette and Brown) due to differing interests.
02-10-2026
Ballard Power Systems Inc. filed a Form 6-K with the SEC on October 2, 2026, reporting the launch of its Fleet360 services for new North American FCmove®-HD+ fleets at APTA EXPO 2026. The announcement, dated October 1, 2026, highlights the company's expansion into aftermarket service offerings for its fuel cell products. No financial figures were provided in this filing.
- · Filing is a Form 6-K under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
- · Commission File Number: 000-53543.
- · The company's principal executive office is located at 9000 Glenlyon Parkway, Burnaby, BC V5J 5J8, Canada.
- · The company files annual reports under Form 40-F (not Form 20-F).
- · The news release was dated October 1, 2026, and the report was signed on October 1, 2026.
02-10-2026
Empery Digital Inc. (formerly Volcon, Inc.) filed a DEFA14A (Definitive Additional Proxy Soliciting Materials) with the SEC on October 2, 2026, as definitive additional proxy materials. The filing is related to the company's proxy statement and does not contain any specific financial results or quantitative performance data.
- · Filing is a DEFA14A (Additional Definitive Proxy Soliciting Materials) filed on October 2, 2026.
- · The filer is Empery Digital Inc., which changed its name from Volcon, Inc. on July 31, 2025, and from an earlier name on October 23, 2020.
- · The company's fiscal year ends on December 31 and it is incorporated in Delaware.
- · The filing contains no financial statements, revenue figures, or earnings data.
02-10-2026
Angel Studios, Inc. (ANGX) entered into a Second Amended and Restated Agreement and Plan of Merger to acquire Toothy Cow Productions, LLC through a merger of the company into its wholly owned subsidiary, Angel TCP Merger Sub, LLC. The merger consideration will be paid in shares of Angel Studios Class A Common Stock valued at $5.65 per share, with the transaction intended to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code. The agreement was signed on September 17, 2026, and amends prior agreements dated November 14, 2025, and June 29, 2026.
- · The merger is structured as a tax-free reorganization under Section 368(a) of the Internal Revenue Code.
- · The agreement is the second amendment and restatement of the original merger agreement dated November 14, 2025.
- · Key Operators of Toothy Cow Productions will execute Support Agreements and Key Operator Restriction Agreements.
- · The Buyer Stock Price is fixed at $5.65 per share of Buyer Common Stock.
- · The accounting firm for the transaction is Tanner LLP.
02-10-2026
Mayfair Gold Corp. filed a Form 6-K with the SEC for October 2026, primarily to incorporate a Material Change Report dated October 1, 2026, into its registration statement. The filing is a routine procedural disclosure by the Canadian gold exploration company and does not contain any financial results or operational data.
- · The filing incorporates Exhibit 99.1 (Material Change Report dated October 1, 2026) by reference into Registration Statement Form F-10 (File No. 333-295084).
- · The company's principal executive offices are located at 489 McDougall Street, Matheson, Ontario P0K 1N0, Canada.
- · The company files annual reports under Form 40-F.
02-10-2026
Lexaria Bioscience Corp. filed an S-3 registration statement with the SEC on October 1, 2026, allowing selling stockholders to offer and sell shares of common stock from time to time. The company highlights progress in its DehydraTECH drug delivery technology, including a chronic human study (GLP-1-H24-4) that met safety endpoints and showed a 54.9% reduction in GI adverse events for DehydraTECH-semaglutide and 60.6% for DehydraTECH-tirzepatide versus Rybelsus. However, the DehydraTECH formulations did not achieve comparable or improved weight loss versus the Rybelsus control, and the company continues to face risks typical of a development-stage biotechnology firm.
- · The registration statement gives retroactive effect to a 1-for-15 reverse stock split effective July 29, 2026.
- · The S-3 covers shares held by selling stockholders, not a primary offering by the company.
- · DehydraTECH-semaglutide formulation was top for HbA1c reduction but not statistically significant vs Rybelsus.
- · DehydraTECH-CBD arm showed meaningful blood pressure reductions, though not a study endpoint.
- · Results from GLP-1-H26-7 are anticipated in Q2 FY2027; results from GLP-1-A26-1 in Q1 FY2027.
- · GLP-1-A26-2 is the first investigation of DehydraTECH with retatrutide and amycretin.
02-10-2026
Southport Acquisition Corp. II, a blank check company, filed a prospectus for an initial public offering of 20,000,000 units at $10.00 per unit, aiming to raise $200,000,000. The offering includes a structure where each unit consists of one Class A ordinary share and one-half of a redeemable warrant, with the sponsor and underwriters also participating in a private placement. The filing details significant dilution risks for public shareholders due to the sponsor's nominal purchase price for founder shares and the anti-dilution rights of those shares, while also noting that no business combination target has been identified.
- · The warrants become exercisable 30 days after the completion of the initial business combination and expire five years after.
- · The underwriters have a 45-day option to purchase up to an additional 3,000,000 units to cover over-allotments.
- · Public shareholders have redemption rights upon completion of the initial business combination, but those holding more than 15% of shares sold in the offering are restricted from redeeming more than 15% without the company's prior consent if a shareholder vote is held.
- · The sponsor purchased 7,666,667 Class B ordinary shares for $25,000 (approx. $0.003 per share), leading to immediate and substantial dilution for public shareholders.
- · The anti-dilution provision of the founder shares could result in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion to maintain the founder share count at 25% of all ordinary shares.
- · Prior to the initial business combination, only holders of Class B ordinary shares have the right to vote to appoint/remove directors and on continuing the company outside the Cayman Islands.
- · The non-managing sponsor investors have expressed interest in purchasing 200,000 private placement units for $2,000,000 and will receive indirect interests in 1,600,000 founder shares.
- · An employee of CCM will purchase membership interests representing 20,000 private placement units and have an indirect interest in 160,000 founder shares.
- · Each independent director has received an indirect interest in 60,667 founder shares for their services.
02-10-2026
Omnitek Engineering Corp. acquired Hard Rock Ready Mix, LLC via an Exchange Agreement on September 29, 2026, issuing 10,000 shares of Series A Preferred Stock to Hard Rock Holdco, LLC, making Hard Rock a wholly-owned subsidiary. Concurrently, the company issued a warrant to Hawkeye Digital, Inc. for 16,666,667 common shares at $0.004 per share for consulting services. In leadership changes, Werner Funk resigned as President, CEO, CFO, and Secretary on October 1, 2026, and was replaced by Kevin Jay Hayes Jr., who also became a director; Brett Kiker was also appointed as a director. No financial performance data is provided in this filing.
- · The Exchange Agreement closed on October 1, 2026.
- · Warrant has a cashless exercise feature and customary anti-dilution adjustments.
- · Werner Funk was appointed Vice President after his resignation as President/CEO/CFO/Secretary.
- · Kevin Jay Hayes Jr. is the sole owner of Hard Rock Holdco, LLC, which holds 15,000 shares of Series A Preferred Stock.
- · No financial statements or pro forma financials were filed with this 8-K.
02-10-2026
Helus Pharma Inc. filed a Form 6-K with the SEC on October 2, 2026, for the month of October 2026, incorporating a Material Change Report dated October 1, 2026, by reference into its registration statement. The filing, signed by CFO Greg Cavers, indicates a material change occurred at the company, but the specific nature of the change is not disclosed in the provided text.
- · The filing incorporates a Material Change Report (Exhibit 99.1) by reference into Registration Statement on Form F-10 (File No. 333-292294).
- · The company's principal executive offices are located at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9.
- · The company indicates it will file annual reports under Form 40-F.
02-10-2026
Verdera Energy Corp. filed a Form 6-K with the SEC for October 2026, submitting a news release dated October 1, 2026. The filing is a routine foreign issuer report and does not contain any financial results, material transactions, or performance data.
- · Filing type: Form 6-K (Foreign Private Issuer Report)
- · Commission File Number: 333-295440
- · Exhibit 99.1 is a News Release dated October 1, 2026
- · Registrant address: #250 – 750 West Pender St., Vancouver, British Columbia, V6C 2T7, Canada
- · Registrant files annual reports under Form 20-F
Get daily alerts with 10 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Pre-Market SEC Filings Roundup
🇺🇸 More from United States
View all →September 24, 2026
USA Corporate Events Calendar — September 24, 2026
USA Corporate Events Calendar
September 24, 2026
USA Earnings Calls Schedule — September 24, 2026
USA Earnings Calls Schedule
September 24, 2026
US Executive Compensation Proxy SEC Filings — September 24, 2026
US Executive Compensation Proxy SEC Filings
September 24, 2026
US Earnings Financial Results SEC Filings — September 24, 2026
US Earnings Financial Results SEC Filings